Literature DB >> 6427982

The effects of a calcium antagonist (nimodipine) on basal cerebral blood flow and reactivity to various agonists.

T A McCalden, R G Nath, K Thiele.   

Abstract

In vitro studies suggest that cerebrovascular contraction is more dependent on the influx of calcium to smooth muscle than general systemic arteries. The present study tested the in vivo effects of a calcium influx blocker (nimodipine) on cerebral blood flow and metabolism in 16 baboons. The 133xenon clearance technique was used together with careful control of EEG and blood gases. With normal blood gases intravenous nimodipine infusion (1 microgram/kg/min) produced an 18% increase in cerebral blood flow with no alteration in cerebral oxidative metabolism or blood pressure. Higher doses (above 10 micrograms/kg/min) resulted in a decreased arterial blood pressure and a return to control cerebral flow. Infusion of the dose producing maximal increase in flow, decreased the cerebral reactivity to altered PCO2 (n = 5). These results suggest that nimodipine may be a relatively selective cerebrovascular dilator.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427982     DOI: 10.1161/01.str.15.3.527

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

Review 1.  Drug treatment of stroke. Current status and future prospects.

Authors:  C A Sila; A J Furlan
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

2.  Cerebrovascular autoregulation is resistant to calcium channel blockade with nimodipine.

Authors:  T A McCalden; R G Nath
Journal:  Experientia       Date:  1989-03-15

3.  Hypothermic cardiopulmonary bypass for minimally invasive mitral valve plasty in adult moyamoya disease.

Authors:  Cheul-Hong Kim; Ji-Uk Yoon; Hyeon-Jung Lee; Sang-Wook Shin; Ji-Young Yoon; Joo-Yeon Park
Journal:  J Anesth       Date:  2012-02-16       Impact factor: 2.078

Review 4.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 5.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Nimodipine-induced changes in the distribution of carotid blood flow and cardiac output in pentobarbitone-anaesthetized pigs.

Authors:  D J Duncker; J Heiligers; E J Mylecharane; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

7.  Cerebral oxygenation and haemodynamic effects induced by nimodipine in healthy subjects.

Authors:  Daniela Canova; Silvestro Roatta; Giuseppe Micieli; Daniele Bosone
Journal:  Funct Neurol       Date:  2012 Jul-Sep

Review 8.  Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

9.  Nimodipine has no effect on the cerebral circulation in conscious pigs, despite an increase in cardiac output.

Authors:  W J van der Giessen; D J Duncker; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

10.  Nimodipine and early aneurysm operation in good condition SAH patients.

Authors:  L M Auer; L Brandt; U Ebeling; J Gilsbach; U Groeger; A Harders; B Ljunggren; F Oppel; H J Reulen; H Saeveland
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.